Dr. Öğr. Üyesi Yasemin YOZGAT BYRNE

Yayın Ağı

Makaleler 11

1. Enhancing the efficacy of VEGF inhibitors by co-inhibition of HIF in the treatment of glioblastoma.

Harbi E., Byrne Y., Bozbey H. U., Tastekin D., Oncul O., Hosseiny S., et al.

Apoptosis : an international journal on programmed cell death , cilt.31, sa.2, ss.56, 2026 (SCI-Expanded, Scopus)

2. Biochemical and epigenomic dissection of TFIIE function reveals gene-selective requirement in human transcription.

Cevher M. A., Wijerathne P. N., Yozgat Y., Cevher S., Ito K., Cihan A., et al.

Scientific reports , 2026 (SCI-Expanded, Scopus)

3. N-terminal half of MED14 is critical for Mediator-RNA polymerase II interaction and the resulting transcription

Baris Y., Jabbar J., Yozgat Y., Dinccelik-Aslan M., Cigirgan E., Erden M., et al.

JOURNAL OF BIOLOGICAL CHEMISTRY , cilt.301, sa.12, 2025 (SCI-Expanded, Scopus)

4. Splicing variants of versican in CD133+/CD44+prostate cancer stem cells

Ayla S., Karakoc E., Yozgat Byrne Y., Parlayan C., Keskin İ., Karahuseyinoglu S., et al.

PATHOLOGY RESEARCH AND PRACTICE , cilt.260, 2024 (SCI-Expanded, Scopus)

5. CYTOTOXIC EFFECTS OF ARCTIUM MINUS METHANOL EXTRACT ON VARIOUS CANCER CELL LINES ARCTİUM MİNUS METANOL EKSTRESİNİN ÇEŞİTLİ KANSER HÜCRE HATLARI ÜZERİNDE SİTOTOKSİK ETKİLERİ

Sayin Şakul A. A., YOZGAT BYRNE Y., KARADAĞ A. E., ALTINALAN E., Çi̇Men Ş., Okur M. E.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.46, sa.3, ss.742-754, 2022 (Scopus, TRDizin)

6. Squalene attenuates the oxidative stress and activates AKT/mTOR pathway against cisplatin-induced kidney damage in mice

Sakul A., Ozansoy M., Elıbol B., Ayla Ş., Günal M. Y., Yozgat Y., et al.

Turkish Journal of Biology , cilt.43, sa.3, ss.179-188, 2019 (SCI-Expanded, Scopus, TRDizin)

7. N-acetylcysteine suppresses colistimethate sodium-induced nephrotoxicity via activation of SOD2, eNOS, and MMP3 protein expressions

CEYLAN B., Ozansoy M., Kılıç Ü., Yozgat Y., Ercan Ç., Yıldız P., et al.

Renal Failure , cilt.40, sa.1, ss.423-434, 2018 (SCI-Expanded, Scopus)

8. Direct engagement of the PI3K pathway by mutant KIT dominates oncogenic signaling in gastrointestinal stromal tumor

Bosbach B., Rossi F., Yozgat Y., Loo J., Zhang J. Q., Berrozpe G., et al.

Proceedings of the National Academy of Sciences of the United States of America , cilt.114, sa.40, 2017 (SCI-Expanded, Scopus)

9. KIT receptor gain-of-function in hematopoiesis enhances stem cell self-renewal and promotes progenitor cell expansion.

Deshpande S., Bosbach B., Yozgat Y., Park C. Y., Moore M. A. S., Besmer P.

Stem cells (Dayton, Ohio) , cilt.31, sa.8, ss.1683-95, 2013 (SCI-Expanded, Scopus)

10. Imatinib upregulates compensatory integrin signaling in a mouse model of gastrointestinal stromal tumor and is more effective when combined with dasatinib.

Rossi F., Yozgat Y., de Stanchina E., Veach D., Clarkson B., Manova K., et al.

Molecular cancer research : MCR , cilt.8, sa.9, ss.1271-83, 2010 (SCI-Expanded, Scopus)

11. Oncogenic Kit signaling and therapeutic intervention in a mouse model of gastrointestinal stromal tumor.

Rossi F., Ehlers I., Agosti V., Socci N. D., Viale A., Sommer G., et al.

Proceedings of the National Academy of Sciences of the United States of America , cilt.103, sa.34, ss.12843-8, 2006 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 5

1. 199eP Integration of tumor microenvironment in patient derived organoid models helps define precision medicine of colorectal cancer (CRC)

YOZGAT BYRNE Y.

Molecular Analysis for Precision Oncology Congress 2025-ESMO, Paris, Fransa, 11 Eylül 2025, (Tam Metin Bildiri)

2. 91P Investigating the mechanism of cisplatin resistance in relation to the potassium channel KCNMA1 in hexokinase-2 knockout non-small cell lung cancer (NSCLC)

YOZGAT BYRNE Y.

Molecular Analysis for Precision Oncology Congress 2025, Paris, Fransa, 11 Eylül 2025, cilt.10, ss.667, (Tam Metin Bildiri)

3. Hekzokinaz-2 Enzim İnhibitörü Olarak Kullanılabilecek Anti-Kanser Ajanı Özgün Metil Jasmonat Analoglarının Sentezi ve İn-Vitro Çalışmaları

şavluğ ö., SUCU B. O., YOZGAT Y., GÜZEL M.

5. İLAÇ KİMYASI: İLAÇ ETKİN MADDESİ TASARIMI, SENTEZİ, ÜRETİMİ VE STANDARDİZASYONU KONGRESİ, Türkiye, 30 Mart - 02 Nisan 2017 Sürdürülebilir Kalkınma

4. The Moleculer Mechanism of Squalen on Cisplatin-induced Nefrotoxicity

ŞAKUL A. A., OZANSOY M., AYLA Ş., GÜNAL M. Y., YOZGAT Y., KAZANCIOĞLU R., et al.

42. Ulusal Fizyoloji Kongresi, Düzce, Türkiye, 5 - 08 Eylül 2016, (Özet Bildiri)

5. Sgualenin Cisplatin Nefrotoksisitesi Üzerine Etkisinin Moleküler Mekanizması

SAYIN ŞAKUL A. A., OZANSOY M., AYLA Ş., GÜNAL M. Y., YOZGAT Y., KAZANCIOĞLU R., et al.

42. Ulusal Fizyoloji Kongresi, Düzce, Türkiye, 5 - 08 Eylül 2016, (Özet Bildiri)

Yayınlar & Eserler